3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Lymphoma, Follicular
7
Lymphoma, Non-Hodgkin
4
Lymphoma, Mantle-Cell
3
Lymphoma, Large B-Cell, Diffuse
3
Lymphoma
3
Leukemia, Lymphocytic, Chronic, B-Cell
3
Lymphoma, B-Cell
2
Waldenstrom Macroglobulinemia
1
Neoplasms
1
Lymphoma, B-Cell, Marginal Zone
1
Hematologic Neoplasms
1
Interventions
Dexamethasone
43
Lenalidomide
26
daratumumab
23
Bortezomib
23
pomalidomide
22
Cyclophosphamide
16
Specimen Handling
14
Biopsy
14
carfilzomib
13
Magnetic Resonance Spectroscopy
11
talquetamab
10
iberdomide
9
fludarabine
9
Calcium Dobesilate
9
isatuximab
8
Melphalan
8
belantamab mafodotin
7
selinexor
5
fludarabine phosphate
5
X-Rays
5
elotuzumab
4
Whole-Body Irradiation
4
Nuclear Medicine Department, Hospital
4
trametinib
3
tocilizumab
3
dexamethasone acetate
3
dexamethasone 21-phosphate
3
dabrafenib
3
auricularum
3
Thalidomide
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Multiple Myeloma
×
Bendamustine Hydrochloride
×
30 days
×
Clear all
No trials found.